Sign in or Register   Sign in or Register
  |  

HIV-1 gp120

Attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. This interaction induces a structural rearrangement creating a high affinity binding site for a chemokine coreceptor like CXCR4 and/or CCR5. Acts as a ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on endothelial cells of liver sinusoids and lymph node sinuses. These interactions allow capture of viral particles at mucosal surfaces by these cells and subsequent transmission to permissive cells. HIV subverts the migration properties of dendritic cells to gain access to CD4+ T-cells in lymph nodes. Virus transmission to permissive T-cells occurs either in trans (without DCs infection, through viral capture and transmission), or in cis (following DCs productive infection, through the usual CD4-gp120 interaction), thereby inducing a robust infection. In trans infection, bound virions remain infectious over days and it is proposed that they are not degraded, but protected in non-lysosomal acidic organelles within the DCs close to the cell membrane thus contributing to the viral infectious potential during DCs' migration from the periphery to the lymphoid tissues. On arrival at lymphoid tissues, intact virions recycle back to DCs' cell surface allowing virus transmission to CD4+ T-cells.
Full Name
Envelope glycoprotein GP120
Function
Attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. This interaction induces a structural rearrangement creating a high affinity binding site for a chemokine coreceptor like CXCR4 and/or CCR5. Acts as a ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on endothelial cells of liver sinusoids and lymph node sinuses. These interactions allow capture of viral particles at mucosal surfaces by these cells and subsequent transmission to permissive cells. HIV subverts the migration properties of dendritic cells to gain access to CD4+ T-cells in lymph nodes. Virus transmission to permissive T-cells occurs either in trans (without DCs infection, through viral capture and transmission), or in cis (following DCs productive infection, through the usual CD4-gp120 interaction), thereby inducing a robust infection. In trans infection, bound virions remain infectious over days and it is proposed that they are not degraded, but protected in non-lysosomal acidic organelles within the DCs close to the cell membrane thus contributing to the viral infectious potential during DCs' migration from the periphery to the lymphoid tissues. On arrival at lymphoid tissues, intact virions recycle back to DCs' cell surface allowing virus transmission to CD4+ T-cells.
Biological Process
Actin filament reorganization Source: UniProtKB-UniRule
Clathrin-dependent endocytosis of virus by host cell Source: UniProtKB
Fusion of virus membrane with host endosome membrane Source: UniProtKB-UniRule
Fusion of virus membrane with host plasma membrane Source: UniProtKB
Mitigation of host immune response by virus Source: UniProtKB-UniRule
Positive regulation of establishment of T cell polarity Source: UniProtKB-UniRule
Positive regulation of plasma membrane raft polarization Source: UniProtKB-UniRule
Positive regulation of receptor clustering Source: UniProtKB-UniRule
Viral protein processing Source: UniProtKB
Virion attachment to host cell Source: UniProtKB
Cellular Location
Virion membrane; Host cell membrane; Host endosome membrane. The surface protein is not anchored to the viral envelope, but associates with the extravirion surface through its binding to TM. It is probably concentrated at the site of budding and incorporated into the virions possibly by contacts between the cytoplasmic tail of Env and the N-terminus of Gag.
PTM
Highly glycosylated by host. The high number of glycan on the protein is reffered to as 'glycan shield' because it contributes to hide protein sequence from adaptive immune system.
Palmitoylation of the transmembrane protein and of Env polyprotein (prior to its proteolytic cleavage) is essential for their association with host cell membrane lipid rafts. Palmitoylation is therefore required for envelope trafficking to classical lipid rafts, but not for viral replication.
Specific enzymatic cleavages in vivo yield mature proteins. Envelope glycoproteins are synthesized as a inactive precursor that is heavily N-glycosylated and processed likely by host cell furin in the Golgi to yield the mature SU and TM proteins. The cleavage site between SU and TM requires the minimal sequence [KR]-X-[KR]-R. About 2 of the 9 disulfide bonds of gp41 are reduced by P4HB/PDI, following binding to CD4 receptor.

Anti-HIV-1 gp120 antibodies

Loading...
Target: HIV-1 gp120
Host: Human
Antibody Isotype: IgG
Specificity: HIV-1
Clone: b12
Application*: Neut., ELISA, IP, IF
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG2a
Specificity: HIV-1
Clone: CBMC-C0510
Application*: E, IF, WB
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV-1
Clone: CBMC-C1128
Application*: E, IF, IP
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: HIV-1
Clone: CBMC-C1113
Application*: E, WB
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV-1
Clone: CBMC-C0854
Application*: E, IF, IP
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV-1
Clone: CBMC-C1018
Application*: E, IF, IP, WB
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG2b
Specificity: HIV
Clone: CBMW-H0768
Application*: DB, IF, WB
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG2a
Specificity: HIV
Clone: CBMW-H0767
Application*: E, IF, WB
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0765
Application*: E, C
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0763
Application*: E, N
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0761
Application*: DB, IH, WB
Target: HIV-1 gp120
Host: Rabbit
Antibody Isotype: IgG
Specificity: HIV
Clone: CBMW-H0759
Application*: E, IF, F
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG
Specificity: HIV
Clone: CBMW-H0758
Application*: E, F, IC, WB
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0389
Application*: WB, E
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG2b
Specificity: HIV
Clone: CBMW-H0379
Application*: E, IC, IH, IP, N, WB
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0264
Application*: E
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0101
Application*: E, WB
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG1
Specificity: HIV
Clone: CBMW-H0045
Application*: E, IF, WB
Target: HIV-1 gp120
Host: Mouse
Antibody Isotype: IgG2a
Specificity: HIV
Clone: CBMW-H0735
Application*: E, IF, WB
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
IFImmunofluorescence
IHImmunohistochemistry
IPImmunoprecipitation
WBWestern Blot
EELISA
MMicroarray
CIChromatin Immunoprecipitation
FFlow Cytometry
FNFunction Assay
IDImmunodiffusion
RRadioimmunoassay
TCTissue Culture
GSGel Supershift
NNeutralization
BBlocking
AActivation
IInhibition
DDepletion
ESELISpot
DBDot Blot
MCMass Cytometry/CyTOF
CTCytotoxicity
SStimulation
AGAgonist
APApoptosis
IMImmunomicroscopy
BABioassay
CSCostimulation
EMElectron Microscopy
IEImmunoelectrophoresis
PAPeptide Array
ICImmunocytochemistry
PEPeptide ELISA
MDMeDIP
SHIn situ hybridization
IAEnzyme Immunoassay
SEsandwich ELISA
PLProximity Ligation Assay
ECELISA(Cap)
EDELISA(Det)
BIBioimaging
IOImmunoassay
LFLateral Flow Immunoassay
LALuminex Assay
CImmunohistochemistry-Frozen Sections
PImmunohistologyp-Paraffin Sections
ISIntracellular Staining for Flow Cytometry
MSElectrophoretic Mobility Shift Assay
RIRNA Binding Protein Immunoprecipitation (RIP)
Go to
Compare